Final Analysis of a Randomized Phase III Trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG0701)

被引：1
|
作者：
Kodaira, T. [1 ]
Kagami, Y. [2 ]
Shibata, T. [3 ]
Shikama, N. [4 ]
Hiraoka, M. [5 ]
Nishimura, Y. [6 ]
Ishikura, S. [7 ]
Nakamura, K. [3 ]
Saito, Y. [8 ]
Matsumoto, Y. [9 ]
Konishi, K. [10 ]
Ito, Y. [11 ]
Akimoto, T. [12 ]
Nakata, K. [13 ]
Toshiyasu, T. [14 ]
Nakagawa, K. [15 ]
Nagata, Y. [16 ]
Nishimura, T. [17 ]
Uno, T. [18 ]
Kataoka, M. [19 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Nagoya, Aichi, Japan
[2] Showa Univ Hosp, Dept Radiat Oncol, Shinagawa Ku, Tokyo, Japan
[3] Natl Canc Ctr, Japan Clin Oncol Grp Data Ctr, Operat Off, Tokyo, Japan
[4] Saitama Med Univ, Int Med Ctr, Dept Radiol Oncol, Hidaka City, Japan
[5] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Kyoto, Japan
[6] Kindai Univ, Dept Radiat Oncol, Fac Med, Osaka, Japan
[7] Koshigaya Municipal Hosp, Dept Radiol, Koshigaya, Japan
[8] Saitama Canc Ctr, Dept Radiat Oncol, Saitama, Japan
[9] Niigata Canc Ctr Hosp, Dept Radiat Oncol, Niigata, Japan
[10] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka, Japan
[11] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
[12] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, Kashiwa, Chiba, Japan
[13] Sapporo Med Univ, Dept Radiol, Sapporo, Hokkaido, Japan
[14] JFCR, Dept Radiat Oncol, Canc Inst Hosp, Tokyo, Japan
[15] Tokyo Univ Hosp, Dept Radiol, Tokyo, Japan
[16] Hiroshima Univ Hosp, Dept Radiat Oncol, Hiroshima, Japan
[17] Shizuoka Canc Ctr, Div Radiat Oncol, Shizuoka, Japan
[18] Chiba Univ, Grad Sch Med, Diagnost Radiol & Radiat Oncol, Chiba, Japan
[19] Shikoku Canc Ctr, Dept Radiat Oncol, Shikoku, Ehime, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 05期
关键词：
D O I：
10.1016/j.ijrobp.2016.09.052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LBA-8
引用
收藏
页码：940 / 940
页数：1
相关论文
共 50 条
  • [21] Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
    Du, Yajing
    Shao, Shali
    Lv, Minghe
    Zhu, Yi
    Yan, Li
    Qiao, Tiankui
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [22] Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer
    Wu, Sangang
    Zhou, Juan
    Ren, Yufeng
    Sun, Jiayuan
    Li, Fengyan
    Lin, Qin
    Lin, Huanxin
    He, Zhenyu
    INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 (05) : 394 - 398
  • [23] The role of surgery in older patients with T1-2N0M0 small cell lung cancer: A propensity score matching analysis
    Ning, Jing
    Ge, Tao
    Zhu, Shuncang
    Han, Yingli
    Ruan, Suhong
    Ma, Yuchen
    Liu, Rentao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904)
    Sasaki, Keita
    Nomura, Motoo
    Kato, Ken
    Sakanaka, Katsuyuki
    Ito, Yoshinori
    Kadota, Tomohiro
    Machida, Ryunosuke
    Kataoka, Tomoko
    Minashi, Keiko
    Tsubosa, Yasuhiro
    Kajiwara, Takeshi
    Fukuda, Haruhiko
    Takeuchi, Hiroya
    Mizowaki, Takashi
    Nishimura, Yasumasa
    Kitagawa, Yuko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 103 - 107
  • [25] Adjuvant radiotherapy in combined treatment of breast cancer T1-2N0-1M0
    Musabaeva, L.I.
    Zhogina, Zh.A.
    Slonimskaya, E.M.
    Meditsinskaya Radiologiya I Radiatsionnaya Bezopasnost', 2002, 47 (04): : 55 - 62
  • [26] Results of institutional differences in treatment planning for a multi-institutional trial of stereotactic radiotherapy for T1N0M0 lung cancer (JCOG0403)
    Matsuo, Y
    Takayama, K
    Nagata, Y
    Kunieda, E
    Tateoka, K
    Mizowaki, T
    Norihisa, Y
    Sakamoto, M
    Hiraoka, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S407 - S408
  • [27] Addition of Chemotherapy is Associated With a Survival Detriment for Early Stage (T1-2N0M0) Glottic Squamous Cell Carcinoma Treated With Definitive Radiation Therapy
    Wang, C.
    Kishan, A. U.
    Raldow, A.
    Beron, P. J.
    Wong, D. J.
    St John, M.
    Steinberg, M. L.
    Chin, R. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1330 - 1330
  • [28] Risk factors for axillary lymph node metastases in clinical stage T1-2N0M0 breast cancer patients
    Zhang, Yuanxin
    Li, Ji
    Fan, Yuan
    Li, Xiaomin
    Qiu, Juanjuan
    Zhu, Mou
    Li, Hongjiang
    MEDICINE, 2019, 98 (40)
  • [29] Concomitant chemotherapy and radiotherapy in conservative treatment of breast cancer T1-2N0M0.
    Semiglazov, V
    Kanaev, S
    Bugrova, I
    Ivanov, V
    Barash, N
    Ivanova, O
    ANNALS OF ONCOLOGY, 2000, 11 : 20 - 21
  • [30] RADIATION-THERAPY FOR EARLY GLOTTIC CANCER (T1N0M0) .1. RESULTS OF CONVENTIONAL OPEN-FIELD TECHNIQUE
    TESHIMA, T
    CHATANI, M
    INOUE, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (06): : 1199 - 1202
12345